LoadingLoadingLoading40 funds hold it.Insiders net selling.
Net buying: insiders sold $0 and bought $2M on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
Unlock the full resultsLast report
Nov 4, 2026
Financial period
Third Quarter 2026
Earnings per share
$1.65 expected
Revenue
$104.69B expected
Full-Year 2026 guidance
$420.00B
No comparable estimate
Estimates as of Nov 7, 2026
EPS expected
$1.08 to $1.36
Revenue expected
19 analysts
Last 30 days
Analysts cutting estimates
Estimate drift
Change in 30 days
| Quarter / reported | Earnings per share | Beat or miss | Revenue / income | Revenue vs last year |
|---|---|---|---|---|
| Sep 30, 2026Reported Nov 4, 2026 | $2.09est. $1.65 | +26.60%beat | $108.40Best. $104.69B+3.54% | +5.4%from $102.87B |
| Jun 30, 2026Reported Aug 5, 2026 | $2.58est. $1.85 | +39.36%beat | $106.10BSEC filing | +7.3%from $98.92B |
| Mar 31, 2026Reported May 6, 2026 | $2.57est. $2.21 | +16.48%beat | $100.43BAlpha Vantage | +6.2%from $94.59B |
| Dec 31, 2025Reported Feb 10, 2026 | $1.09est. $1.00 | +9.38%beat | $105.69BAlpha Vantage | +8.2%from $97.71B |
| Sep 30, 2025Reported Oct 29, 2025 | $1.60est. $1.36 | +17.65%beat | $102.87BSEC filing | +7.8%from $95.43B |
| Jun 30, 2025Reported Jul 31, 2025 | $1.81est. $1.46 | +23.97%beat | $98.92BSEC filing | +8.4%from $91.23B |
| Mar 31, 2025Reported May 1, 2025 | $2.25est. $1.67 | +34.73%beat | $94.59BAlpha Vantage | +7.0%from $88.44B |
| Dec 31, 2024Reported Feb 12, 2025 | $1.19est. $0.92 | +29.35%beat | $97.71BAlpha Vantage | +4.2%from $93.81B |
Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.
| USD | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $105.69B | $100.43B | $106.10B | $108.40B |
| Cost of what it sold | $92.13B | $84.80B | $90.35B | $93.50B |
| Gross profit | $13.57B | $15.62B | $15.75B | $14.90B |
| What it spent | ||||
| Other operating costs | $11.46B | $10.94B | $11.05B | $11.33B |
| Total operating expenses | $11.46B | $10.94B | $11.05B | $11.33B |
| What was left | ||||
| Operating profit | $2.11B | $4.68B | $4.70B | $3.57B |
| Interest on debt | $787.0M | $774.0M | $757.0M | $747.0M |
| Profit before tax | $1.35B | $3.94B | $3.98B | $2.85B |
| Tax | -$1.57B | $995.0M | $982.0M | $678.0M |
| Net profit | $2.94B | $2.94B | $3.00B | $2.17B |
| EBITDA | $3.29B | $5.83B | $5.86B | $4.73B |
This stock is under pressure.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage is bullish
Cigna’s third-quarter earnings show a drop in income from its pharmacy benefit business
NeutralNov 6Ubiquiti Inc. (NYSE:UI) Shares to Pay Quarterly Dividend of $1.00
Leans bullishNov 6Stryker Corp Stock (SYK) Moved Down by 3.23% on Nov 6: What Investors Need To Know
Leans bullishNov 6Middleby (NASDAQ:MIDD) Stock Price Target Raised at Canaccord Genuity Group
NeutralNov 6Intuitive Surgical Inc Stock (ISRG) Moved Down by 3.14% on Nov 6: Drivers Behind the Movement
Leans bullishNov 6WesBanco (NASDAQ:WSBC) Stock: Insider Scott Love Sells 3,000 Shares
NeutralNov 6Cardinal Health Raises FY2027 Guidance Despite 28% Profit Drop In Medical Products Segment
Leans bullishNov 6Cardinal Health Raises FY2027 Guidance Despite 28% Profit Drop In Medical Products Segment
Leans bullishNov 622 macro signals shaping CVS right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results
